ACET
Adicet Bio (ACET)
$47
About Adicet Bio (ACET)
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Details
Daily high
$0.50
Daily low
$0.46
Price at open
$0.50
52 Week High
$1.11
52 Week Low
$0.45
Market cap
75.9M
Dividend yield
0.00%
Volume
15,660
Avg. volume
2.4M
P/E ratio
-.39
Adicet Bio News
Details
Daily high
$0.50
Daily low
$0.46
Price at open
$0.50
52 Week High
$1.11
52 Week Low
$0.45
Market cap
75.9M
Dividend yield
0.00%
Volume
15,660
Avg. volume
2.4M
P/E ratio
-.39